ACM
FMTX

AlphaCrest Capital Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

AlphaCrest Capital Management’s Portfolio FMTX Stock Details FMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-71,383
Closed -$1.01M – 1459
2021
Q4 		$1.01M Buy
+71,383
New +$1.24M 0.04% 781

Other funds holding FMTX

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AlphaCrest Capital Management's FMTX Position: Q1 2022 in Review

AlphaCrest Capital Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q1 2022, closing a stake of 71,383 shares — an estimated $1.01M sold.

AlphaCrest Capital Management first reported a position in FMTX in Q4 2021 and held it in 1 quarter. The position peaked at $1.01M in Q4 2021. 98 funds tracked by Wall St. Rank hold FMTX as of Q1 2022.

  • AlphaCrest Capital Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • AlphaCrest Capital Management sold 71,383 Forma Therapeutics Holdings, Inc. Common Stock shares in Q1 2022, an estimated $1.01M.
  • AlphaCrest Capital Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q4 2021 and held it in 1 quarter.
  • AlphaCrest Capital Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $1.01M in Q4 2021.
  • 98 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q1 2022.

Based on AlphaCrest Capital Management's 13F filing for Q1 2022, filed 12 May 2022.